10 Patents
- US125761332026Antigen-binding Agents That Specifically Bind Epidermal Growth Factor Receptor Variant III
National Research Council Of Canada
0 cites - US125401862026Anti-egfrviii Antibodies and Antigen-binding Fragments Thereof
National Research Council Of Canada
0 cites - US124284602025Engineered Tgf-beta Monomers and Their Use for Inhibiting Tgf-beta Signaling
National Research Council Of Canada
0 cites - 0 cites
- US123917432025Tgf-β-receptor Ectodomain Fusion Molecules and Uses Thereof
National Research Council Of Canada
0 cites - US123927772025Antibody Variants with Ph-dependent Antigen Binding for Selective Targeting of Solid Tumors
National Research Council Of Canada
0 cites - US120845102024Antibodies Selective for Cells Presenting EGFR at High Density
National Research Council Of Canada
0 cites - US119458582024Antibodies and Antibody Fragments Against HNAV1.7 Channel and Their Use in Pain and Cancer Indications
NATIONAL RESEARCH COUNCIL OF CANADA
0 cites - US118664812024Tgf-β-receptor Ectodomain Fusion Molecules and Uses Thereof
National Research Council Of Canada
0 cites - US115914082023Antibody Glycoconjugates and Methods of Production and Use
National Research Council Of Canada
0 cites